drugset
drugset / Trial / NCT06396819

Collagen-povidone for Diabetic Seniors' Tenosynovitis

NCT06396819 ↗

Phase 4 Completed 25 enrolled Mexican Social Security Institute
RandomizedCrossoverSingle-blindTreatment

Summary

Diabetes affects 415 million adults globally, leading to hand issues. Povidone collagen shows promise in managing tenosynovitis. A clinical trial was conduced to compared its efficacy in adults over 60. It is shown that the intervention reduces pain, improves functionality, and grip strength with no complications. Collagen povidone holds potential for treating diabetic hand issues.

Timeline

Start
2023-01-01
Primary completion
2024-01-01
Completion
2024-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Collagen povidone Unknown 0.2 ml Topical

Indications

No indication recorded.